CYCLIN-DEPENDENT KINASE 4

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 16:55:42 GMT 2025` Edited by `admin` on `Tue Apr 01 16:55:42 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	5M46696SR5
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CYCLIN-DEPENDENT KINASE 4

Common Name

English

CELL DIVISION PROTEIN KINASE 4

Preferred Name

English

CDK4

Common Name

English

PSK-J3

Common Name

English

Code System Code Type Description

PHAROS

P11802

Created by admin on Tue Apr 01 16:55:42 GMT 2025 , Edited by admin on Tue Apr 01 16:55:42 GMT 2025

PRIMARY

UNIPROT

P11802

Created by admin on Tue Apr 01 16:55:42 GMT 2025 , Edited by admin on Tue Apr 01 16:55:42 GMT 2025

PRIMARY

FDA UNII

5M46696SR5

Created by admin on Tue Apr 01 16:55:42 GMT 2025 , Edited by admin on Tue Apr 01 16:55:42 GMT 2025

PRIMARY

Related Record Type Details


					W49YFX3FPQ

Ulecaciclib

INHIBITOR -> TARGET

Amount:


					RB6Y814V4I

AMG-925

INHIBITOR -> TARGET

Amount:


					ZPX6CRU43V

CIMPUCICLIB

INHIBITOR -> TARGET

Amount:


					W66XP666AM

VORUCICLIB

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					9EK26WE8QN

RIVICICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					4V8ECV0NBQ

DINACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					QJ8RO3296G

NARAZACICLIB

INHIBITOR -> TARGET

Amount:


					3B512HJD65

EBVACICLIB

INHIBITOR -> TARGET


					45AD6X575G

ALVOCIDIB

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					6MC966B505

FN-1501

INHIBITOR -> TARGET


					AX8OYB2MWW

PF-06842874

INHIBITOR -> TARGET


					G9ZF61LE7G

PALBOCICLIB

INHIBITOR -> TARGET


					Q6460P4C0B

Inixaciclib

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO, IN-VIVO

Amount:


					5ZHA5P4PFX

DALPICICLIB

INHIBITOR -> TARGET


					0W9Q8U337A

RONICICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					Z6BYC0F36E

AVOTACICLIB

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					MKS45S912B

PHA-793887

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					WBH8AY6ENB

LEROCICLIB

INHIBITOR -> TARGET

Amount:


					U6072DO9XG

Trilaciclib

INHIBITOR -> TARGET

Amount:


					60UAB198HK

Abemaciclib

INHIBITOR -> TARGET

Comments:

CELL-FREE KINASE ASSY (CDK4/CYCLIN D1)

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					CRB7BT5JDQ

Tibremciclib

INHIBITOR -> TARGET

Amount:


					TK8ERE8P56

RIBOCICLIB

INHIBITOR -> TARGET


					29713BMI56

ZK-304709

INHIBITOR -> TARGET

Amount:


					X1BF92PW9T

AT-7519

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					1GAJ98SC2X

RGB-286638 FREE BASE

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					484EDA7KEM

N-(4-(1-CYCLOPROPYL-4-FLUORO-2-METHYL-1H-BENZO(D)IMIDAZOL-6-YL)-5-FLUOROPYRIMIDIN-2-YL)-6-(2-(DIMETHYLAMINO)ETHYL)-5,6,7,8-TETRAHYDRO-L,6-NAPHTHYRIDIN-2-AMINE

INHIBITOR -> TARGET

Interaction Type:

PRECLINICAL

Qualification:

IC50

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_1]				N-ACETYLALANINE	26C4VY6Z0M
AMINO ACID SUBSTITUTION	[1_171]				THREONINE PHOSPHATE	3L4WX7B1EI

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL